Related references
Note: Only part of the references are listed.Treatment selection in metastatic renal cell carcinoma: expert consensus
Bernard Escudier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Vascular Endothelial Growth Factor Receptor-3 Directly Interacts with Phosphatidylinositol 3-Kinase to Regulate Lymphangiogenesis
Sanja Coso et al.
PLOS ONE (2012)
Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
Michael T. Dellinger et al.
PLOS ONE (2011)
Targeting lymphatic vessel functions through tyrosine kinases
Steven P. Williams et al.
VASCULAR CELL (2010)
Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model
M. Yashiro et al.
BRITISH JOURNAL OF CANCER (2009)
Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo
Elena V. Kurenova et al.
CELL CYCLE (2009)
Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies
Axel Grothey et al.
CANCER JOURNAL (2008)
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis
Caroline A. Heckman et al.
CANCER RESEARCH (2008)
Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
Timothy P. Padera et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tuomas Tammela et al.
NATURE (2008)
Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores
Kenji Kuroda et al.
PROSTATE (2008)
Molecular markers and mortality in prostate cancer
John Concato et al.
BJU INTERNATIONAL (2007)
Inhibtion of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2
N Roberts et al.
CANCER RESEARCH (2006)
Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma
AA Roma et al.
MODERN PATHOLOGY (2006)
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix
Z Gombos et al.
CLINICAL CANCER RESEARCH (2005)
Lymphatic vessel density and lymph node metastasis in prostate cancer
YP Zeng et al.
PROSTATE (2005)
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis
K Jennbacken et al.
PROSTATE (2005)
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor
JM Lin et al.
CANCER RESEARCH (2005)
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels
YL He et al.
CANCER RESEARCH (2005)
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease
G Di Lorenzo et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer
YP Zeng et al.
CLINICAL CANCER RESEARCH (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Role of stroma in carcinogenesis of the prostate
GR Cunha et al.
DIFFERENTIATION (2002)
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors
MMT Mattila et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Distribution of vascular endothelial growth factor (VEGF) in prostate disease
K Walsh et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2002)
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma
M Skobe et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression
ML George et al.
NEOPLASIA (2001)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
SA Stacker et al.
NATURE MEDICINE (2001)
Share Paper
